Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Mouse
63%
Cohort Study
53%
Disease
52%
Colorectal Cancer
47%
Neoplasm
45%
Inflammation
40%
Chronic Kidney Failure
36%
IC50
33%
Lung Cancer
32%
Cytotoxicity
25%
Reactive Oxygen Metabolite
25%
Injury
23%
Biological Marker
23%
Breast Cancer
23%
Liver Cell Carcinoma
22%
Histone Deacetylase Inhibitor
22%
Anticarcinogen
22%
Non Small Cell Lung Cancer
21%
Chronic Obstructive Lung Disease
21%
Traumatic Brain Injury
20%
Epidermal Growth Factor Receptor
19%
Pharmacokinetics
19%
Diabetes Mellitus
18%
Hemodialysis
18%
Tumor Growth
18%
Antioxidant
17%
Brain Ischemia
17%
Tumor Necrosis Factor
17%
Colon Cancer
17%
Histone Deacetylase
17%
Cardiovascular Disease
16%
Tubulin
15%
Macrogol
15%
Histone Deacetylase 6
14%
Cancer Growth
14%
Adverse Event
14%
Prostate Cancer
14%
Prevalence
14%
High Performance Liquid Chromatography
14%
Western Blot
14%
Alzheimer's Disease
14%
Mouse Model
13%
Caspase 3
13%
Non Insulin Dependent Diabetes Mellitus
13%
Chemotherapy
13%
Protein P53
13%
Sleep Disordered Breathing
13%
Drug Delivery System
13%
Micelle
12%
Combination Therapy
12%
Asthma
12%
Polycyclic Aromatic Hydrocarbon
12%
Cytokine
12%
Nanoparticle
12%
Cell Viability
12%
Doxorubicin
12%
Lung Adenocarcinoma
12%
Lipopolysaccharide
12%
Parkinson's Disease
12%
Randomized Controlled Trial
11%
Phosphotransferase
11%
Cisplatin
11%
Interleukin 6
11%
Antitumor Activity
11%
Hydroxamic Acid
11%
Well Water
10%
Ethanol
10%
Infection
10%
Carcinogenesis
10%
Receptor
10%
End Stage Renal Disease
10%
Hyperlipidemia
10%
Nuclear Factor
10%
Bioavailability
10%
Nephrotoxicity
9%
Antiproliferative Activity
9%
Metastasis
9%
Cigarette Smoking
9%
Long Term Exposure
9%
Pancreas Cancer
9%
Calcium Ion
9%
Survival Rate
9%
Symptom
9%
Mitogen Activated Protein Kinase
9%
Placebo
9%
Vasculotropin
9%
Transitional Cell Carcinoma
9%
Case-Control Study
9%
Clinical Trial
9%
Small Interfering RNA
8%
Tablet
8%
Chitosan
8%
Drug Release
8%
Gelatinase B
8%
Anti-Inflammatory Drug
8%
Wound Healing
8%
Neuroprotective Agent
8%
Nitric Oxide
8%
Vaccination Policy
8%
Medicine and Dentistry
Cohort Analysis
41%
Apoplexy
39%
Chronic Kidney Disease
31%
Malignant Neoplasm
30%
In Vitro
28%
Cancer Cell
27%
Programmed Cell Death
24%
Disease
23%
Colorectal Cancer
23%
Neoplasm
21%
Hazard Ratio
21%
Odds Ratio
19%
Biological Marker
18%
Lung Cancer
17%
Meta-Analysis
17%
Injury
16%
Diabetes
16%
Metastatic Carcinoma
15%
Breast Cancer
15%
Traumatic Brain Injury
15%
Brain Ischemia
15%
Chronic Obstructive Pulmonary Disease
14%
Systematic Review
14%
Signal Transduction
13%
Cell Proliferation
13%
Randomized Controlled Trial
12%
Retrospective Cohort Study
12%
Alzheimer's Disease
11%
Particular Matter 2.5
11%
Maturity Onset Diabetes of the Young
11%
Hemodialysis
10%
End Stage Renal Disease
10%
Proportional Hazards Model
10%
Diabetes Mellitus
10%
Cancer Growth
9%
Rectum Cancer
9%
Gene Expression
9%
Autophagy
9%
Drug Therapy
9%
Hepatocellular Carcinoma
9%
Atmospheric Aerosol
8%
Cardiovascular Disease
8%
Cell Migration
8%
Tumor Progression
8%
Obstructive Sleep Apnea
8%
Isotopes of Calcium
8%
Acute Kidney Injury
8%
Symptom
8%
Prevalence
8%
Urinary System
8%
Cytotoxicity
8%
Colon Cancer
7%
Cancer Therapy
7%
Upregulation
7%
Parkinson's Disease
7%
Epidermal Growth Factor Receptor
7%
Adverse Event
7%
Non Small Cell Lung Cancer
7%
Logistic Regression Analysis
7%
Oxidative Stress
7%
Health Care Cost
7%
Survival Rate
7%
Medicine
7%
Histone Deacetylase
6%
Ischemic Heart Disease
6%
Infection
6%
Activating Transcription Factor 3
6%
Kidney Function
6%
Cardiovascular System
6%
Xenograft
6%
Reactive Oxygen Species
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Case-Control Study
6%
Endothelial Cell
6%
COVID-19
6%
Calcium Ion
6%
Angiogenesis
6%
Carcinogenesis
5%
Histone Deacetylase Inhibitor
5%
Elderly Patient
5%
microRNA
5%
Cell Death
5%
Nephropathy
5%
Coronary Artery
5%
Supplementation
5%
Influenza Vaccination
5%
Kawasaki Disease
5%
Transitional Cell Carcinoma
5%
Protein P53
5%
Overall Survival
5%
IC50
5%
Computer Assisted Tomography
5%
Endothelial Progenitor Cell
5%
Vascular Smooth Muscle Cell
5%
Surgery
5%
Blood Pressure
5%
Metabolite
5%
Prostate Cancer
5%
Extracellular Matrix
5%
Antineoplastic Activity
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
70%
Mouse
27%
Cohort Study
25%
Signal Transduction
23%
Single-Nucleotide Polymorphism
20%
Gene Expression
19%
Cell Migration
19%
Colon
17%
Cell Proliferation
16%
Messenger RNA
15%
Genotyping
15%
Anticancer
15%
Proteomics
14%
Promoter Region
13%
Epidermal Growth Factor Receptor
13%
Upregulation
13%
Autophagy
13%
Tumor Progression
12%
Protein Expression
12%
Hemodialysis
12%
MicroRNA
12%
Carcinogenesis
12%
Genetics
12%
Cell Death
12%
Glucose-Regulated Protein
11%
Cell Growth
11%
Allele
11%
Eicosanoid Receptor
10%
down Regulation
10%
Genetic Divergence
10%
Genome-Wide Association Study
10%
Methylation
10%
Mesenchymal-Epithelial Transition
9%
Histone Deacetylase
9%
P53
9%
Oxidative Stress
9%
Western Blot
8%
IC50
8%
Thrombomodulin
8%
Enzyme
8%
Macrophage
8%
Angiogenesis
8%
Phosphotransferase
8%
Homeostasis
8%
Catenin
8%
Kinase
8%
Alternative Splicing
7%
Survival Rate
7%
Genetic Polymorphism
7%
Heat Shock Protein
7%
Cytotoxicity
7%
Transcription
7%
Overall Survival
7%
Isoform
7%
Cell Cycle
7%
Protein Motif
7%
RNA Recognition Motif
7%
Fibroblast
6%
Prevalence
6%
Mitochondrion
6%
Interleukin 8
6%
Adipocyte
6%
Lipid
6%
Case-Control Study
6%
Hypoxia Inducible Factor 1
6%
Drug Resistance
6%
Metabolic Pathway
5%
Kidney Function
5%
Blood Level
5%
Protein Kinases
5%
Caspase
5%
Transcription Factors
5%
Small Interfering RNA
5%
Skeletal Muscle
5%
Caspase 3
5%
DNA Repair
5%
Low-Density Lipoprotein
5%
Tau
5%
Cyclooxygenase
5%
Particulate Matter
5%
K-Complex
5%
Wild Type
5%
Antineoplastic Activity
5%
Normal Human
5%
Tumor Necrosis Factor
5%
Doxorubicin
5%
Synapsin I
5%
Heme Oxygenase
5%
Stem Cell
5%
Gene Polymorphism
5%
Genetic Determinism
5%
Microarrays
5%